| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bioventus Inc. (BVS) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. BVS is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 161.2K | $1.48M | - | |
| VP | 144.4K | $1.32M | - | |
| CEO | 117.0K | $1.07M | - | |
| Dir | 116.6K | $1.07M | - | |
| VP | 59.9K | $549.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2023 | Singleton Mark Leonard46 | SVP &CFO | Sell | 6,044 | $1.27 | $7,675.88 | -32.5% | +129.0% | +315.3% | |
| Mar 15, 2023 | D'adamio Anthony61 | SVP &General Counsel | Sale+OE | 3,409 | $1.39 | $4,737.49 | -7.0% | +89.6% | +218.4% | |
| Mar 15, 2023 | Reali Kenneth Michael | Chief Executive Officer | Sale+OE | 9,811 | $1.39 | $13,624.54 | -24.6% | +89.6% | +218.4% | |
| Mar 15, 2023 | Church Katrina J52 | SVP &Chief Compliance Officer | Sale+OE | 1,332 | $1.39 | $1,849.62 | -22.4% | +89.6% | +218.4% | |
| Oct 3, 2022 | Nosenzo John84 | Fmr. Chief Commercial Officer | Sell | 142 | $8.81 | $1,251.15 | - | -62.7% | -57.4% | |
| Oct 3, 2022 | Church Katrina J52 | SVP &Chief Compliance Officer | Sell | 131 | $7.69 | $1,007.39 | -0.4% | -62.7% | -57.4% | |
| Apr 4, 2022 | D'adamio Anthony61 | SVP &General Counsel | Sale+OE | 16,016 | $11.19 | $179,238.26 | -28.5% | -43.9% | -91.7% | |
| Apr 4, 2022 | Nosenzo John84 | Chief Commercial Officer | Sale+OE | 65,963 | $11.12 | $733,501.96 | -44.0% | -43.9% | -91.7% | |
| Apr 4, 2022 | Pavesio Alessandra | SVP &Chief Science Officer | Sale+OE | 32,997 | $11.17 | $368,424.70 | -18.2% | -43.9% | -91.7% | |
| Feb 14, 2022 | Pavesio Alessandra | SVP &Chief Science Officer | Sell | 433 | $11.99 | $5,191.67 | -0.4% | -29.9% | -85.6% |